These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31522677)

  • 1. Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.
    Müller GA; Wied S; Herling AW
    Biochemistry (Mosc); 2019 Aug; 84(8):954-962. PubMed ID: 31522677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    Chang E; Kim DH; Yang H; Lee DH; Bae SH; Park CY
    PLoS One; 2018; 13(10):e0206152. PubMed ID: 30365523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
    Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
    Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A).
    Müller GA; Herling AW; Wied S; Müller TD
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32085406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
    Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
    Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle.
    Palacios-González B; Zarain-Herzberg A; Flores-Galicia I; Noriega LG; Alemán-Escondrillas G; Zariñan T; Ulloa-Aguirre A; Torres N; Tovar AR
    Biochim Biophys Acta; 2014 Jan; 1841(1):132-40. PubMed ID: 24013029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet.
    Flamment M; Gueguen N; Wetterwald C; Simard G; Malthièry Y; Ducluzeau PH
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1162-70. PubMed ID: 19724020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB
    Chen W; Liu H; Guan H; Xue N; Wang L
    Eur J Pharmacol; 2017 Nov; 814():232-239. PubMed ID: 28844874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase N2 regulates AMP kinase signaling and insulin responsiveness of glucose metabolism in skeletal muscle.
    Ruby MA; Riedl I; Massart J; Åhlin M; Zierath JR
    Am J Physiol Endocrinol Metab; 2017 Oct; 313(4):E483-E491. PubMed ID: 28720584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism.
    Le Bacquer O; Lanchais K; Combe K; Van Den Berghe L; Walrand S
    J Cell Physiol; 2021 Apr; 236(4):2669-2683. PubMed ID: 32885412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
    Cota D; Sandoval DA; Olivieri M; Prodi E; D'Alessio DA; Woods SC; Seeley RJ; Obici S
    Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.
    Xin C; Liu J; Zhang J; Zhu D; Wang H; Xiong L; Lee Y; Ye J; Lian K; Xu C; Zhang L; Wang Q; Liu Y; Tao L
    Int J Obes (Lond); 2016 Mar; 40(3):443-51. PubMed ID: 26403433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
    Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
    Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel small-molecule AMP-activated protein kinase allosteric activator with beneficial effects in db/db mice.
    Zhang LN; Xu L; Zhou HY; Wu LY; Li YY; Pang T; Xia CM; Qiu BY; Gu M; Dong TC; Li JY; Shen JK; Li J
    PLoS One; 2013; 8(8):e72092. PubMed ID: 23977216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle.
    Smith AC; Bruce CR; Dyck DJ
    J Physiol; 2005 Jun; 565(Pt 2):537-46. PubMed ID: 15774530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.
    Herling AW; Kilp S; Elvert R; Haschke G; Kramer W
    Endocrinology; 2008 May; 149(5):2557-66. PubMed ID: 18276749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
    Jorgačević B; Vučević D; Vesković M; Mladenović D; Vukićević D; Vukićević RJ; Todorović V; Radosavljević T
    Can J Physiol Pharmacol; 2019 Feb; 97(2):120-129. PubMed ID: 30673308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway.
    Zheng X; Sun T; Wang X
    Biochem Biophys Res Commun; 2013 Jul; 436(3):377-81. PubMed ID: 23747418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.